Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
We do not allow the human consumption of our products
The figure 25.3 % surpasses: Tirzepatide SURMOUNT-1: 22.5 % Semaglutide STEP-1: 14.9 % Retatrutide Phase 2: 24.2 % (comparable, but Phase 3 results for Retatrutide are still lacking) It raises the question whether CagriSema will be the first molecule with an effect truly comparable to bariatric surgery (typically 2530 % reduction)
[2] Chang CH, Tsai WC, Hsu YH, Pang JH
Therefore, a personalized treatment plan is always recommended
US$ 23.15
US$ 29.37
US$ 28.48
US$ 26.41
